Maintenance Therapy with Olaparib Shows Strong Benefit in Advanced Ovarian Cancer

20:20 EDT 21 Oct 2018 | NEJM

Olaparib seems to improve progression-free survival in patients with newly diagnosed advanced ovarian cancer, according to an industry-funded trial presented at the European...

More From BioPortfolio on "Maintenance Therapy with Olaparib Shows Strong Benefit in Advanced Ovarian Cancer"